Long-Run Variances of Trending and Mean-Reverting Assets

Follow us on LinkedIn

Trading strategies are often loosely divided into two categories: trend-following and mean-reverting. They’re designed to exploit the mean-reverting or trending properties of asset prices. These properties are often investigated through time series techniques or Hurst exponent. Reference [1] provided, however, a different perspective and approach for studying the mean-reverting and trending properties of assets. It compared the long-run variances of mean-reverting and trending assets to that of a random-walk process. It stated,

We have explored using a probabilistic model for investment styles to show that the variance of a financial asset is directly dependent on the probability of moving in the same direction on successive days. The theoretical analysis shows that variance may actually be reduced through reversal strategies – capturing the case that the asset is more likely to move in opposing directions on subsequent days. We have applied a simple model to US stock data, showing that such a regime is indeed prevalent in 97 of the largest stocks and thereby proven that relative to a random walk the variance of these stocks is actually reduced as a result of this frenetic behaviour. Indeed such a result suggests that these stocks are actually more predictable than a random walk due to this artefacct.

In short, the paper concluded that most large-cap US stocks are mean-reverting, and the mean reversion resulted in a reduction of the variances of the assets. This means that mean-reverting asset prices are more predictable as compared to a random walk. The opposite is true for trending assets: larger variances and less predictability.

It’s refreshing to find a paper that elegantly combined theoretical and empirical research. Our observations are as follows,

  • It’s not surprising that most large-cap stocks exhibit mean-reverting behavior, especially in the daily timeframe.
  • The paper suggested that mean-reverting strategies have lower variances than trending-following ones, but it did not provide a proof. Intuitively, this could be true, since mean-reverting strategies operate in a more predictable space, hence they have smaller variances. Also, this is consistent with the empirical fact that mean-reverting strategies have higher win rates.
  • The above claim can be investigated through numerical simulations.
  • Trend-following strategies can be designed to exploit the expansion of variances, i.e. capturing the tail risks, by letting the profit run. But note that empirically they have lower win rates.

References

[1] L. Middleton, J. Dodd, S. Rijavec, Trading styles and long-run variance of asset prices, 2021, arXiv:2109.08242

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSThe South Park stock market jinx could be coming for high-flying weight-loss stocks
The South Park stock market jinx could be coming for high-flying weight-loss stocks

An analysis found that a stock underperformed the S&P 500 by a median of 7% in the year after being featured in the animated comedy.

Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: CollPlant reports Q1 2024 results and corporate updates
Earnings call: CollPlant reports Q1 2024 results and corporate updates
Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: Covalon turns profitable with strong Q2 performance
Earnings call: Covalon turns profitable with strong Q2 performance
Stay up-to-date with the latest news - click here
LATEST NEWSUS health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
Stay up-to-date with the latest news - click here
LATEST NEWSBESREMi ® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
BESREMi ® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
Stay up-to-date with the latest news - click here

Leave a Reply